Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Posted on November 30, 2012 at 12:15 PM EST
MINYANVILLE ORIGINAL There’s plenty to keep biotechnology and drug company investors busy this holiday season: New study data potential marketing approvals panel reviews and maybe even a quarterly dividend increase from the big gorilla of biotech. Below are a number of highlights for the month of December. As always some dates are subject to change. December 4 The San Antonio Breast Cancer Symposium is held through December 8. The latest treatment diagnosis and prevention of breast cancer is the focus of this annual event. Roche (PINK:RHHBY) Novartis (NYSE:NVS) Geron (NASDAQ:GERN) Puma Biotechnology (NASDAQ:PBYI) and Galena Biopharma (NASDAQ:GALE) are among ...